The role of the sensor kinase, QseC, an adrenergic receptor of Escherichia coli, in bacterial translocation during hemorrhagic shock

2016 ◽  
Vol 80 (6) ◽  
pp. 972-976 ◽  
Author(s):  
Jun Meng ◽  
Yun-chao Huang ◽  
Jie Huang ◽  
Kun Yang
1990 ◽  
Vol 30 (8) ◽  
pp. 942-952 ◽  
Author(s):  
EDWIN A. DEITCH ◽  
WILLIAM BRIDGES ◽  
LI MA ◽  
RODNEY BERG ◽  
ROBERT D. SPECIAN ◽  
...  

1994 ◽  
Vol 36 (4) ◽  
pp. 482-485 ◽  
Author(s):  
Harm M. Dijkstra ◽  
Herma Z. Apperloo-Renkema ◽  
Willem L. Manson ◽  
Dick van der Waaij ◽  
Henk J. Klasen

2005 ◽  
Vol 187 (19) ◽  
pp. 6770-6778 ◽  
Author(s):  
Nadim Majdalani ◽  
Michael Heck ◽  
Valerie Stout ◽  
Susan Gottesman

ABSTRACT The rcs phosphorelay pathway components were originally identified as regulators of capsule synthesis. In addition to the transmembrane sensor kinase RcsC, the RcsA coregulator, and the response regulator RcsB, two new components have been characterized, RcsD and RcsF. RcsD, the product of the yojN gene, now renamed rcsD, acts as a phosphorelay between RcsC and RcsB. Transcription of genes for capsule synthesis (cps) requires both RcsA and RcsB; transcription of other promoters, including that for the small RNA RprA, requires only RcsB. RcsF was described as an alternative sensor kinase for RcsB. We have examined the role of RcsF in the activation of both the rprA and cps promoters. We find that a number of signals that lead to activation of the phosphorelay require both RcsF and RcsC; epistasis experiments place RcsF upstream of RcsC. The RcsF sequence is characteristic of lipoproteins, consistent with a role in sensing cell surface perturbation and transmitting this signal to RcsC. Activation of RcsF does not require increased transcription of the gene, suggesting that modification of the RcsF protein may act as an activating signal. Signals from RcsC require RcsD to activate RcsB. Sequencing of an rcsC allele, rcsC137, that leads to high-level constitutive expression of both cps and rprA suggests that the response regulator domain of RcsC plays a role in negatively regulating the kinase activity of RcsC. The phosphorelay and the variation in the activation mechanism (dependent upon or independent of RcsA) provide multiple steps for modulating the output from this system.


2014 ◽  
Vol 70 (1) ◽  
pp. 391-398 ◽  
Author(s):  
Kun Yang ◽  
Jun Meng ◽  
Yun-chao Huang ◽  
Lian-hua Ye ◽  
Guang-jian Li ◽  
...  

Shock ◽  
2001 ◽  
Vol 16 (1) ◽  
pp. 59-63 ◽  
Author(s):  
Tomoharu Shimizu ◽  
Tohru Tani ◽  
Kazuyoshi Hanasawa ◽  
Yoshihiro Endo ◽  
Masashi Kodama

2002 ◽  
Vol 184 (4) ◽  
pp. 1204-1208 ◽  
Author(s):  
D. J. Clarke ◽  
S. A. Joyce ◽  
C. M. Toutain ◽  
A. Jacq ◽  
I. B. Holland

ABSTRACT The Rcs two-component pathway is involved in the regulation of capsule production in Escherichia coli. RcsC is predicted to be the sensor component of this two-component pathway, and in this study we present the first genetic data that support the role of RcsC as a hybrid sensor kinase.


2020 ◽  
Vol 3 (1) ◽  
pp. 43-57 ◽  
Author(s):  
Russel J Reiter ◽  
Qiang Ma ◽  
Ramaswamy Sharma

This review summarizes published reports on the utility of melatonin as a treatment for virus-mediated diseases. Of special note are the data related to the role of melatonin in influencing Ebola virus disease. This infection and deadly condition has no effective treatment and the published works documenting the ability of melatonin to attenuate the severity of viral infections generally and Ebola infection specifically are considered. The capacity of melatonin to prevent one of the major complications of an Ebola infection, i.e., the hemorrhagic shock syndrome, which often contributes to the high mortality rate, is noteworthy. Considering the high safety profile of melatonin, the fact that it is easily produced, inexpensive and can be self-administered makes it an attractive potential treatment for Ebola virus pathology.  


Sign in / Sign up

Export Citation Format

Share Document